"10.1371_journal.pone.0042418","plos one","2012-08-14T00:00:00Z","Helmi M'Kada; Hugo Perazzo; Mona Munteanu; Yen Ngo; Nittia Ramanujam; Bruno Fautrel; Françoise Imbert-Bismut; Vlad Ratziu; Ina Schuppe-Koistinen; Véronique Leblond; Jean Yves Delattre; Yves Samson; Olivier Lyon Caen; François Bricaire; David Khayat; Charles Pierrot-Deseilligny; Serge Herson; Zahir Amoura; Patrick Tilleul; Olivier Deckmyn; Pierre Coriat; Vincent Nicolas Delpech; Philippe Boulogne; Dominique Bonnefont-Rousselot; Thierry Poynard; for the Drug Induced Liver Injury Groupe Hospitalier Pitié-Salpêtrière (DILI-GHPS) Group and the Safer and Faster Evidence-based Translation (SAFE-T) Consortium","Service de Biochimie Métabolique, Groupe Hospitalier Pitié-Salpêtrière (GHPS), Assistance Publique Hôpitaux de Paris (AP-HP), Paris, France; AP-HP, University Pierre Marie Curie (UPMC) Liver Center, Paris, France; Biopredictive, Paris, France; Rheumatology Unit, GHPS, Paris, France; Astra Zeneca, Södertälje, Sweden; Hematology Unit, GHPS, Paris, France; Neurology-2 Unit, GHPS, Paris, France; Cerebral Vascular Emergency Unit, GHPS, Paris, France; Neurology-4 GHPS, Paris, France; Infectious Disease Unit GHPS, Paris, France; Oncology Unit GHPS, Paris, France; Neurology-1 GHPS, Paris, France; Internal Medicine-2 GHPS, Paris, France; Internal Medicine-1 GHPS, Paris, France; Pharmacology Unit, GHPS, Paris, France; Intensive Care Anesthesiology GHPS, Paris, France; Administrative Direction GHPS, Paris, France; Information Technology Unit GHPS, Paris, France; EA 4466, Faculté des Sciences Pharmaceutiques et Biologiques, Université Paris Descartes, Sorbonne Paris Cité, Paris, France","Conceived and designed the experiments: TP HM. Performed the experiments: HM HP MM YN NR VR FIB BF VL JYD YS OLC FB DK CPD SH ZA PT OD PC VND PB DBR TP ISK. Analyzed the data: TP HM FIB MM. Wrote the paper: TP HM FIB MM.","ISK is full-time employee of Astra-Zeneca. Thierry Poynard is the inventor of the liver injury biomarkers, FibroTest ActiTest, and has a capital interest in Biopredictive, the company marketing the tests. Patents belong to the public organization Assistance Publique Hôpitaux de Paris. Mona Munteanu and Yen Ngo are full-time employees of Biopredictive, the company marketing FibroTest (FibroSure in the USA). This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials.","2012","08","Helmi M'Kada","HMK",26,TRUE,2,25,4,4,TRUE,TRUE,FALSE,0,NA,FALSE
